Clinical

Dataset Information

0

Medical Food for the Dietary Management of Metastatic Colorectal Cancer


ABSTRACT: This is a single arm study evaluating the tolerability and markers of colorectal cancer with a specially designed medical food restricted in specific amino acids for the dietary management of subjects with metastatic colorectal cancer. Subjects will be receiving two FDA approved second line drug therapies, fluoropyrimidine and oxaliplatin ± bevacizumab (FOLFIRI + BEV) that are routinely prescribed in combination for metastatic colorectal cancer as part of their routine care.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2400333 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2018-05-04 | GSE113990 | GEO
| PRJNA454804 | ENA
2018-09-17 | GSE119472 | GEO
2020-07-10 | GSE129843 | GEO
2021-06-09 | GSE162917 | GEO
2023-07-20 | GSE232525 | GEO
2021-06-09 | GSE162918 | GEO
2012-04-02 | GSE32512 | GEO
2012-04-01 | E-GEOD-32512 | biostudies-arrayexpress
| PRJEB35803 | ENA